Viatris (VTRS) Invested Capital (2019 - 2026)
Viatris (VTRS) posted Invested Capital of $27.6 billion for Q2 2026, down 4.79% on a QoQ basis from $29.0 billion in Q1 2026, and down 8.09% year-over-year from $30.0 billion in Q2 2025.
Analysis
Viatris (VTRS) Invested Capital (2019 - 2026) Analysis & Trends
Viatris has reported Invested Capital for 8 years, with the latest figure at $27.6 billion in Q2 2026.
- On a quarterly basis, Invested Capital fell 8.09% year-over-year to $27.6 billion in Q2 2026; TTM through Jun 2026 was $27.6 billion, a 8.09% decrease from a year earlier, with the FY2025 full-year figure at $29.1 billion, down 10.88% from the prior year.
- Invested Capital was $27.6 billion for Q2 2026 at Viatris, down from $29.0 billion in the prior quarter.
- The five-year high for Invested Capital was $42.5 billion in Q1 2022, with the low at $27.6 billion in Q2 2026.
- Average Invested Capital over 5 years is $35.5 billion, with a median of $37.3 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Invested Capital advanced 0.2% in 2023, then decreased 21.45% in 2025.
- Over 5 years, Invested Capital stood at $40.3 billion in 2022, then fell by 4.33% to $38.6 billion in 2023, then fell by 15.33% to $32.7 billion in 2024, then retreated by 10.88% to $29.1 billion in 2025, then decreased by 5.2% to $27.6 billion in 2026.
- The last three Invested Capital figures came in at $27.6 billion (Q2 2026), $29.0 billion (Q1 2026), and $29.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 24.35 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 27.61 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 4.90 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 2.70 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 19.84 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.15 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 898.70 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.38 Bn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.61 Bn |
| Mar 31, 2026 | 29.00 Bn |
| Dec 31, 2025 | 29.13 Bn |
| Sep 30, 2025 | 29.66 Bn |
| Jun 30, 2025 | 30.04 Bn |
| Mar 31, 2025 | 29.84 Bn |
| Dec 31, 2024 | 32.68 Bn |
| Sep 30, 2024 | 35.54 Bn |
| Jun 30, 2024 | 36.62 Bn |
| Mar 31, 2024 | 37.98 Bn |
| Dec 31, 2023 | 38.60 Bn |
| Sep 30, 2023 | 39.25 Bn |
| Jun 30, 2023 | 39.45 Bn |
| Mar 31, 2023 | 39.71 Bn |
| Dec 31, 2022 | 40.35 Bn |
| Sep 30, 2022 | 39.17 Bn |
| Jun 30, 2022 | 41.05 Bn |
| Mar 31, 2022 | 42.47 Bn |
| Dec 31, 2021 | 43.58 Bn |
| Sep 30, 2021 | 44.61 Bn |